|
|
Volumn 78, Issue 2, 1996, Pages 195-198
|
|
Adoptive immunotherapy for nonsmall cell lung carcinoma: A fourth treatment modality, complicated radiation sensitizer, or none of the above
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
CYCLOPHOSPHAMIDE;
ETOPOSIDE;
IFOSFAMIDE;
INTERLEUKIN 2;
MITOMYCIN C;
VINBLASTINE;
ADOPTIVE IMMUNOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
EDITORIAL;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
LUNG NON SMALL CELL CANCER;
LYMPHOKINE ACTIVATED KILLER CELL;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RADIOSENSITIVITY;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
COMBINED MODALITY THERAPY;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
INTERLEUKIN-2;
LUNG NEOPLASMS;
LYMPHOCYTES, TUMOR-INFILTRATING;
RADIATION TOLERANCE;
RADIATION-SENSITIZING AGENTS;
SURVIVAL RATE;
|
|
EID: 0029680699
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1097-0142(19960715)78:2<195::AID-CNCR1>3.0.CO;2-L Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
